NDC Active Ingredient Brentuximab Vedotin

Active Ingredient Information

What is Brentuximab Vedotin?

Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.

What is the usage for Brentuximab Vedotin?

Brentuximab is used to treat certain types of cancers (Hodgkin's lymphoma, systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, primary cutaneous anaplastic large cell lymphoma, CD30-expressing mycosis fungoides). It works by slowing or stopping the growth of cancer cells.

How many products in the NDC database contain Brentuximab Vedotin?

The NDC database has 1 products with the active ingredient Brentuximab Vedotin. The following table lists all the products that have this active ingredient.

NDC Products with Brentuximab Vedotin

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
51144-050Proprietary Name: Adcetris Brentuximab VedotinInjection, Powder, Lyophilized, For SolutionIntravenousSeagen Inc.ACTIVE